Novoprotein(SH:688137) Xin Lang Cai Jing·2026-01-27 01:39Core Viewpoint - The company, Suzhou Nearshore Protein Technology Co., Ltd., has shown a mixed financial performance with a significant increase in revenue but a notable decline in net profit, indicating potential challenges ahead in profitability despite growth in sales [2]. Group 1: Financial Performance - As of January 26, Nearshore Protein's stock price increased by 6.40%, with a trading volume of 233 million yuan [1]. - For the period from January to September 2025, the company achieved a revenue of 112 million yuan, representing a year-on-year growth of 21.48% [2]. - The net profit attributable to shareholders for the same period was -28.86 million yuan, reflecting a year-on-year decrease of 58.06% [2]. Group 2: Shareholder and Market Activity - As of November 10, the number of shareholders for Nearshore Protein was 6,056, a decrease of 0.53% from the previous period [2]. - The average number of circulating shares per shareholder increased by 0.53% to 5,395 shares [2]. - The company has distributed a total of 70.18 million yuan in dividends since its A-share listing [3]. Group 3: Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders included several funds, with Huashang Lexiang Flexible Allocation Mixed A being the third-largest shareholder, holding 604,700 shares, a decrease of 14,800 shares from the previous period [3]. - Huashang Zhenxuan Return Mixed A ranked fourth with 463,100 shares, down by 9,450 shares [3]. - Huashang Yuanjian Value Mixed A increased its holdings by 137,800 shares, ranking fifth with 444,000 shares [3].